Media Summary: The global pharmaceutical industry is constantly innovating, looking forward to discover the next class of Presented By: ​​​​​​​Chris ​Andrews ​​​​​​​Domenico Palumberi Speaker Biography: For more than 20 years, Chris ... During this symposium, U.S. and South African speakers with experience in clinical development shared their experiences and ...

Cell And Gene Therapy Advancing - Detailed Analysis & Overview

The global pharmaceutical industry is constantly innovating, looking forward to discover the next class of Presented By: ​​​​​​​Chris ​Andrews ​​​​​​​Domenico Palumberi Speaker Biography: For more than 20 years, Chris ... During this symposium, U.S. and South African speakers with experience in clinical development shared their experiences and ... In this in-depth keynote from the 2024 CGT Summit hosted by Charles River Laboratories, Dr. Peter Marks, Director of the FDA's ... Hear from Dr. Andrew Byrnes during the third installment of the BIO-ASGCT CGT Science Series. Speaker: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration.

The updated funding concepts include expanded support for large collaborative teams and pairs of investigators, ...

Photo Gallery

Cell and Gene Therapy: Advancing the Next Generation of Pharmaceuticals
McKesson | Always Advancing Cell and Gene Therapy
FDA’s Efforts to Advance the Development and Approval of Cellular and Gene Therapies
How to Advance Cell & Gene Therapies with an Innovative, Flexible Approach
New frontiers of medicine – Cell and Gene Therapies
Advancing Gene and Cell Therapies in South Africa
What is Advanced Therapy?
FDA’s 2024 Vision for Cell & Gene Therapy Innovation
Advancing Cell & Gene Therapy in NJ
Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series
Featured Speaker: Advancing Gene Therapies Great and Small
CIRM’s board approved new and amended funding programs to advance stem cell & gene therapy research
View Detailed Profile
Cell and Gene Therapy: Advancing the Next Generation of Pharmaceuticals

Cell and Gene Therapy: Advancing the Next Generation of Pharmaceuticals

The global pharmaceutical industry is constantly innovating, looking forward to discover the next class of

McKesson | Always Advancing Cell and Gene Therapy

McKesson | Always Advancing Cell and Gene Therapy

"Our group of experts in

FDA’s Efforts to Advance the Development and Approval of Cellular and Gene Therapies

FDA’s Efforts to Advance the Development and Approval of Cellular and Gene Therapies

FEATURED TALK: FDA'S EFFORTS TO

How to Advance Cell & Gene Therapies with an Innovative, Flexible Approach

How to Advance Cell & Gene Therapies with an Innovative, Flexible Approach

Presented By: ​​​​​​​Chris ​Andrews ​​​​​​​Domenico Palumberi Speaker Biography: For more than 20 years, Chris ...

New frontiers of medicine – Cell and Gene Therapies

New frontiers of medicine – Cell and Gene Therapies

Cell and gene therapies

Advancing Gene and Cell Therapies in South Africa

Advancing Gene and Cell Therapies in South Africa

During this symposium, U.S. and South African speakers with experience in clinical development shared their experiences and ...

What is Advanced Therapy?

What is Advanced Therapy?

Advanced therapies

FDA’s 2024 Vision for Cell & Gene Therapy Innovation

FDA’s 2024 Vision for Cell & Gene Therapy Innovation

In this in-depth keynote from the 2024 CGT Summit hosted by Charles River Laboratories, Dr. Peter Marks, Director of the FDA's ...

Advancing Cell & Gene Therapy in NJ

Advancing Cell & Gene Therapy in NJ

Advancing Cell & Gene Therapy in NJ

Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series

Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series

Hear from Dr. Andrew Byrnes during the third installment of the BIO-ASGCT CGT Science Series.

Featured Speaker: Advancing Gene Therapies Great and Small

Featured Speaker: Advancing Gene Therapies Great and Small

Speaker: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration.

CIRM’s board approved new and amended funding programs to advance stem cell & gene therapy research

CIRM’s board approved new and amended funding programs to advance stem cell & gene therapy research

The updated funding concepts include expanded support for large collaborative teams and pairs of investigators, ...

Advanced Therapies Week 2026 Highlights | The Future of Cell & Gene Therapy

Advanced Therapies Week 2026 Highlights | The Future of Cell & Gene Therapy

Advanced